Rho Federal Systems Division, Inc. | ClinicalTrials HQ

12 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Oral Food Challenge Biomarkers (SAFER)	Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, allergic disease, food allergy, immune system disorder	Recruiting	Not stated	2026-10-08		NCT07279467
Belimumab With Rituximab for Primary Membranous Nephropathy	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, membranous glomerulonephritis, nephritis, nephrosis, nephrotic syndrome, urinary system disorder	Recruiting	Phase 2	2026-09-18		NCT03949855
Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy	autoimmune disease, immune system disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, nervous system disorder, neuromuscular disease	Recruiting	Phase 2	2026-09-17		NCT07103746
Efficacy of Tezepelumab in Peanut Oral Immunotherapy	Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder	Recruiting	Phase 2	2026-09-16		NCT07015996
Daratumumab in Primary Antiphospholipid Syndrome	antiphospholipid syndrome, autoimmune disease, immune system disorder	Recruiting	Phase 1 / Phase 2	2026-09-16		NCT05671757
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)	CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis	Recruiting	Phase 3	2026-09-16		NCT04047628
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis	CNS demyelinating autoimmune disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder	Active, not recruiting	Phase 4	2026-09-01		NCT05285891
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder	Recruiting	Phase 1	2026-07-02		NCT06504160
Systems Biology of Early Atopy	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, food allergy, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder	Active, not recruiting	Not stated	2026-05-27		NCT04798079
Carfilzomib and Belatacept for Desensitization	Highly Sensitized Prospective Kidney Transplant Recipients	Active, not recruiting	Phase 1 / Phase 2	2026-04-08		NCT05017545
Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents	Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder	Active, not recruiting	Phase 2	2026-01-20		NCT05347771
Vaginal Microbiome Exposure and Immune Responses in C-section Infants	Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder	Active, not recruiting	Early phase 1	2025-11-05		NCT03567707